Developing Inhaled Generic Medicines – Navigating Complexity and Overcoming Challenges

Previously Aired on December 1st, 2020 

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

The development of inhaled generic medicines presents a number of unique challenges in terms of the product formulation, device design, drug-device combination, reference product performance and the regulatory environment. 

This webinar explores the key considerations and strategies for demonstrating equivalence, accelerating development and reducing late-stage product development risks.

In this webinar you’ll learn:

• How the current regulatory environment impacts the development of inhaled generic medicines

• The application of new techniques and methodologies to increase product understanding

• How to consider equivalence in device design and performance

• The importance of process understanding to enable efficient manufacturing scale-up

Who should attend:

• Pharmaceutical and biotech companies developing inhaled medicines

• Manager/Director/Senior Director/Vice President/SVP, R&D

• Manager/Director/Senior Director/Vice-President/SVP, Product Development

• Manager/Director/Senior Director/Vice President/SVP, Procurement and Sourcing

• Manager/Director/Senior Director/Vice President/SVP, Inhaled Device Development

Presenters

Presenter
Martin Oliver
(Presenter)
Senior Vice President, Delivery Management
DPI & pMDI Platforms
View Biography
Presenter
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review